logo

RDHL

Redhill Biopharma·NASDAQ
--
--(--)
--
--(--)

RDHL fundamentals

Redhill Biopharma (RDHL) released its earnings on Aug 17, 2023: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Aug 17, 2023

Earnings

EPS
Revenue

Revenue & Expenses

RDHL has released its 2023 Q2 earnings report, with revenue of 1.80M, reflecting a YoY change of -90.21%, and net profit of 761.00K, showing a YoY change of 106.50%. The Sankey diagram below clearly presents RDHL's revenue sources and cost distribution.

Key Indicators

Redhill Biopharma (RDHL) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Redhill Biopharma (RDHL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Redhill Biopharma (RDHL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Redhill Biopharma (RDHL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Redhill Biopharma (RDHL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Redhill Biopharma (RDHL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield